Subject: RE: AstraZeneca updated results released
From: Tamar Gabunia </O=EXCHORGANIZATION/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=E6CA04F38EC94D0CADAB9CBDF90FCDDE-TAMAR G>
To: Sebastian-A Molineus <[email-masked]>
Cc: "Nino V. Moroshkina" <[email-masked]>, Volkan Cetinkaya <[email-masked]>, Ahmet Levent Yener <[email-masked]>
Date: Thu, 25 Mar 2021 13:45:32 +0000

Dear Sebastian

Thanks a million for sharing!

Best

Tamar

From: Sebastian-A Molineus [mailto:[email-masked]]
Sent: 25 March, 2021 15:59
To: Tamar Gabunia
Cc: Nino V. Moroshkina ; Volkan Cetinkaya ; Ahmet Levent Yener
Subject: FW: AstraZeneca updated results released

Hi Tamar – am sure you’ve seen, but sharing for info. just in case.

Thank you and kind regards,

Sebastian

Sebastian Molineus
Regional Director for the South Caucasus
Europe and Central Asia
T  +995 (32) 291 6238
M +995 (577) 78 7821
M +1 (202) 492-3914
E  [email-masked]
W www.worldbank.org/en/region/eca

@smolineus

www.linkedin.com/in/molineus/

From: Fadia M. Saadah <[email-masked]>
Sent: Thursday, March 25, 2021 3:18 PM
To: ECA RLT Full <[email-masked]>
Subject: FW: AstraZeneca updated results released

Some good new on AZ

From: David Wilson <[email-masked]>
Sent: Thursday, March 25, 2021 3:10 AM
To: David Wilson <[email-masked]>
Subject: AstraZeneca updated results released

AZ updated efficacy with new cases 76% but they are still assessing some unclear cases. 85% among over 65. 8 severe cases all in control group.

https://www.astrazeneca.com/media-centre/press-releases/2021/azd1222-us-phase-iii-primary-analysis-confirms-safety-and-efficacy.html